Commentary
-
Issue: Vol. 22 No. 6 (2024): Blood Transfusion 6-2024 (November-December)
Publication Date: 2024-09-30
The new SoHO Regulation. What should the blood system expect?
-
Issue: Vol. 22 No. 6 (2024): Blood Transfusion 6-2024 (November-December)
Publication Date: 2024-01-31
Inclusion of cryoprecipitate, pathogen-reduced, in the who model lists of essential medicines for adults and children: a call for action
-
Issue: Vol. 21 No. 5 (2023): Blood Transfusion 5-2023 (September-October)
Publication Date: 2023-03-17
Rituximab in the treatment of immune-mediated thrombotic thrombocytopenic purpura
-
Issue: Vol. 21 No. 5 (2023): Blood Transfusion 5-2023 (September-October)
Publication Date: 2023-02-24
Prevention and treatment of COVID-19 by mono- and poly-clonal antibodies
-
Issue: Blood Transfusion - 4 2022 (July-August)
Publication Date: 2022-04-19
Protecting blood donor health to meet the patient’s needs
-
Issue: Blood Transfusion - 3 2022 (May-June)
Publication Date: 2022-03-09
Platelet-derived immune-modulatory mediators and transfusion: time to consider their effects?
-
Issue: Blood Transfusion - 5 2021 (September-October)
Publication Date: 2021-07-20
Black blood matters
-
Issue: Blood Transfusion - 1 2021 (January-February)
Publication Date: 2020-09-18
Red blood cell morphology in patients with COVID-19-related anaemia
-
Issue: Blood Transfusion - 1 2021 (January-February)
Publication Date: 2020-09-18
Light and shadows of the new therapies for haemophilia treatment in the Covid-19 era
-
Issue: Blood Transfusion - 3 2020 (May-June)
Publication Date: 2020-05-07
COVID-19, thromboembolic risk and thromboprophylaxis: learning lessons from the bedside, awaiting evidence
-
Issue: Blood Transfusion - 3 2020 (May-June)
Publication Date: 2020-05-07
Blood supply and transfusion support in southern Italy: findings during the first four weeks of the SARS-CoV-2 pandemic